Flexible approaches to addressing mRNA vaccine demand

In this webinar, Katarina Stenklo, Enterprise Solutions Commercial Activation leader for Cytiva addresses how flexible approaches can help address considerations and challenges in mRNA manufacturing, such as managing the size, structure and stability of mRNA molecules, the challenges of adapting workflows created for other modalities, and scale up considerations.